CDK6 Is a Therapeutic Target in Myelofibrosis #Leucemia @LeukemiaJnl https://t.co/E7iux8iEHt
1,707 followers
5,188 followers
CDK6 is elevated in #myelofibrosis. CDK inhibitor #Palbociclib in combination with #Ruxolitinib inhibits myelofibrosis in mouse models, which may have therapeutic potential for improving patient treatment. https://t.co/tkYzHtryNy https://t.co/8Uv1sg9pk1
369 followers
CDK6 Is a Therapeutic Target in Myelofibrosis https://t.co/mSRL6rqWjO
28 followers
RT @CR_AACR: CDK6 is elevated in #myelofibrosis. CDK inhibitor #Palbociclib in combination with #Ruxolitinib inhibits myelofibrosis in mous…